For research use only. Not for use in humans.

Bepranemab (Anti-Tau)

Synonyms: UCB 0107 Cat.No.A3066 Purity:99%

Bepranemab (Anti-Tau) is a humanized, full-length IgG4 monoclonal antibody that targets to a central tau epitope (amino acids 235-250).It can be used for Alzheimer’s disease (AD) research. MW :145.92 KD.

Quality Control

Batch: A306601 Purity: 99% Protein concentration: 11.669mg/ml Endotoxin Level: ＜1EU/mg

Cited in Nature Medicine for its top-tier quality
COA
SDS
Datasheet

Mechanism of Action

Description	Bepranemab (Anti-Tau) is a humanized, full-length IgG4 monoclonal antibody that targets to a central tau epitope (amino acids 235-250).It can be used for Alzheimer’s disease (AD) research. MW :145.92 KD.
References	[1] https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.057586

Cell Lines	Assay Type	Concentration	Incubation Time	Formulation	Activity Description	PMID

Product Details

CAS No.	2244960-75-4
Isotype	Human IgG4SP
Source	CHO
Formulation	100 mM Pro-Ac, 20mM Arg, pH5.0
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

^*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.